188 related articles for article (PubMed ID: 29474315)
1. Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus.
Arinuma Y
Curr Opin Neurol; 2018 Jun; 31(3):294-299. PubMed ID: 29474315
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
3. Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.
Kapadia M; Bijelić D; Zhao H; Ma D; Stojanovich L; Milošević M; Andjus P; Šakić B
Acta Neuropathol Commun; 2017 Sep; 5(1):70. PubMed ID: 28882191
[TBL] [Abstract][Full Text] [Related]
4. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
[TBL] [Abstract][Full Text] [Related]
5. [Anti-NMDA receptor antibody in systemic lupus erythematosus].
Gono T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):225-30. PubMed ID: 25069262
[TBL] [Abstract][Full Text] [Related]
6. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
8. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies.
Schwarting A; Möckel T; Lütgendorf F; Triantafyllias K; Grella S; Boedecker S; Weinmann A; Meineck M; Sommer C; Schermuly I; Fellgiebel A; Luessi F; Weinmann-Menke J
Ann Rheum Dis; 2019 Sep; 78(9):1226-1234. PubMed ID: 31186256
[TBL] [Abstract][Full Text] [Related]
9. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
[TBL] [Abstract][Full Text] [Related]
10. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.
Park DJ; Takahashi Y; Kang JH; Yim YR; Kim JE; Lee JW; Lee KE; Lee JK; Lee SS
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):54-60. PubMed ID: 28339361
[TBL] [Abstract][Full Text] [Related]
11. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives.
Steup-Beekman G; Steens S; van Buchem M; Huizinga T
Lupus; 2007; 16(5):329-34. PubMed ID: 17576734
[TBL] [Abstract][Full Text] [Related]
12. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
13. Developmental process in diffuse psychological/neuropsychiatric manifestations of neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yamaoka K
Immunol Med; 2021 Mar; 44(1):16-22. PubMed ID: 32649846
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus.
Colasanti T; Delunardo F; Margutti P; Vacirca D; Piro E; Siracusano A; Ortona E
J Neuroimmunol; 2009 Jul; 212(1-2):3-9. PubMed ID: 19500858
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of circulating anti-N-methyl-
Tay SH; Fairhurst AM; Mak A
Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
[TBL] [Abstract][Full Text] [Related]
16. Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus.
Tay SH; Mak A
Int J Mol Sci; 2015 May; 16(5):10281-300. PubMed ID: 25955648
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors.
Omdal R; Brokstad K; Waterloo K; Koldingsnes W; Jonsson R; Mellgren SI
Eur J Neurol; 2005 May; 12(5):392-8. PubMed ID: 15804272
[TBL] [Abstract][Full Text] [Related]
18. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
[TBL] [Abstract][Full Text] [Related]
19. [Central neuropsychiatric involvement in systemic lupus erythematosus].
Madrane S; Ribi C
Rev Med Suisse; 2012 Apr; 8(337):848-53. PubMed ID: 22594009
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
Mader S; Jeganathan V; Arinuma Y; Fujieda Y; Dujmovic I; Drulovic J; Shimizu Y; Sakuma Y; Stern JNH; Aranow C; Mackay M; Yasuda S; Atsumi T; Hirohata S; Diamond B
Arthritis Rheumatol; 2018 Feb; 70(2):277-286. PubMed ID: 29073350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
